行情

PACB

PACB

太平洋生物科学
NASDAQ

实时行情|Nasdaq Last Sale

4.685
+0.045
+0.97%
盘前: 4.700 +0.015 +0.32% 07:19 11/20 EST
开盘
4.650
昨收
4.640
最高
4.720
最低
4.640
成交量
114.86万
成交额
--
52周最高
7.84
52周最低
4.370
市值
7.17亿
市盈率(TTM)
-6.1816
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

PACB 新闻

  • 全球安全资产越来越稀缺 每年约有4000亿美元的缺口
  • 新浪财经-自媒体综合.3小时前
  • 机构:留学生人数流失使美国经济蒙受百亿美元损失
  • 新浪美股.3小时前
  • 苹果为打造地图服务已投入数十亿美元 欲与谷歌竞争
  • 新浪科技.3小时前
  • 股债油金罕见同涨逾10% 有人却还暴亏27%
  • 新浪财经综合.3小时前

更多

所属板块

先进医疗设备和技术
+1.39%
医疗设备和用品
+1.01%

热门股票

名称
价格
涨跌幅

PACB 简况

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.
展开

Webull提供Pacific Biosciences of California的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。